Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-051714
Filing Date
2021-08-16
Accepted
2021-08-16 19:49:52
Documents
2
Period of Report
2021-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3239
2 POA DOCUMENT poa.txt EX-24.3_1004141 3277
  Complete submission text file 0001209191-21-051714.txt   8036
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Issuer) CIK: 0001824893 (see all company filings)

EIN.: 981556622 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 171 OYSTER POINT BLVD., SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address
Rothenberg Mace (Reporting) CIK: 0001873988 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39635 | Film No.: 211180538